These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 9547332)
1. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. Schneider P; Holler N; Bodmer JL; Hahne M; Frei K; Fontana A; Tschopp J J Exp Med; 1998 Apr; 187(8):1205-13. PubMed ID: 9547332 [TBL] [Abstract][Full Text] [Related]
2. Modulation of death receptor pathways in oncology. de Vries EG; Timmer T; Mulder NH; van Geelen CM; van der Graaf WT; Spierings DC; de Hooge MN; Gietema JA; de Jong S Drugs Today (Barc); 2003; 39 Suppl C():95-109. PubMed ID: 14988748 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand. Knox PG; Milner AE; Green NK; Eliopoulos AG; Young LS J Immunol; 2003 Jan; 170(2):677-85. PubMed ID: 12517928 [TBL] [Abstract][Full Text] [Related]
4. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex. Holler N; Tardivel A; Kovacsovics-Bankowski M; Hertig S; Gaide O; Martinon F; Tinel A; Deperthes D; Calderara S; Schulthess T; Engel J; Schneider P; Tschopp J Mol Cell Biol; 2003 Feb; 23(4):1428-40. PubMed ID: 12556501 [TBL] [Abstract][Full Text] [Related]
5. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively. Kajiwara K; Saito A; Ogata S; Tanihara M Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720 [TBL] [Abstract][Full Text] [Related]
6. Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. Pelli N; Floreani A; Torre F; Delfino A; Baragiotta A; Contini P; Basso M; Picciotto A Clin Exp Immunol; 2007 Apr; 148(1):85-9. PubMed ID: 17302732 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Vargo-Gogola T; Crawford HC; Fingleton B; Matrisian LM Arch Biochem Biophys; 2002 Dec; 408(2):155-61. PubMed ID: 12464266 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder. Ben Bahria-Sediki I; Chebil M; Sampaio C; Martel-Frachet V; Cherif M; Zermani R; Rammeh S; Ben Ammar Gaaied A; Bettaieb A Urol Int; 2018; 100(4):476-484. PubMed ID: 29719304 [TBL] [Abstract][Full Text] [Related]
15. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619 [TBL] [Abstract][Full Text] [Related]
16. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053 [TBL] [Abstract][Full Text] [Related]
17. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing. Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796 [TBL] [Abstract][Full Text] [Related]
18. Soluble Fas and soluble Fas L levels in patients with acute pancreatitis. Endo S; Inoue Y; Fujino Y; Yamada Y; Sato N; Wakabayashi G; Sakamoto T; Ishikura H; Tanaka T; Inada K; Sato S Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):179-86. PubMed ID: 11913710 [TBL] [Abstract][Full Text] [Related]
19. Expression of the functional soluble form of human fas ligand in activated lymphocytes. Tanaka M; Suda T; Takahashi T; Nagata S EMBO J; 1995 Mar; 14(6):1129-35. PubMed ID: 7536672 [TBL] [Abstract][Full Text] [Related]
20. Soluble Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis. Hashimoto H; Tanaka M; Suda T; Tomita T; Hayashida K; Takeuchi E; Kaneko M; Takano H; Nagata S; Ochi T Arthritis Rheum; 1998 Apr; 41(4):657-62. PubMed ID: 9550474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]